normative view of UT derives from its universal sweep and consequent lack of an external criterion. CONCLUSIONS: The normative interpretation of UT leads to circular reasoning or an infinite regress, forcing the recognition that the normative aspect of UT lies in the decision to apply UT, not in UT per se.
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mended to effectively incorporate Japan into global OR plans/protocols: 1) a Japan OR expert should first review draft global OR plans/protocols and prospectively identify critical success factors in Japan, then 2) Japan OR expert should draft Japan plans/protocols, and 3) establish a strong feedback loop from global OR to the Japan OR expert to incorporate Japan input in global plans/ protocols. Critical success factors in Japan include: 1) academic expert assistance; 2) feasibility assessment; 3) institutional commitment; 4) strategic fit with Japan. Building draft Japan plans/protocols requires a preliminary assessment of Japan's medical environment: 1) clinical practice; 2) epidemiology; 3) political, sociological, ethnic and health care financing issues; 4) regulatory issues. Establishing a strong communication link between Japan and global OR will ensure that the Japan plans are integrated into the global OR plans/protocols. CONCLUSION: Global outcomes research plans/protocols must incorporate Japan. Working with a Japan OR expert is highly recommended so that global research plans adequately reflect an awareness of critical success factors and the local medical environment in Japan.
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INTEGRATION OF INTERNATIONAL INPUT INTO INSTRUMENT DESIGN:TRANSLATABILITY ASSESSMENT
Conway K, Mear I Mapi Research Institute, Lyon, France OBJECTIVES: The last 20 years have seen the development of numerous PRO measures mostly however within and for one culture. Based on the assumption that the original concepts are universally appropriate, instruments destined for international use are translated following a standardized procedure (linguistic validation). This process however reveals the interdependence of translation and original and the importance of integrating an international component into the design of instruments, which can be done through a Translatability Assessment. The presentation will illustrate the methodology and the advantages of this new approach. METHODS: A translatability assessment can be defined as an international critical review of a pre-final original in collaboration with the developer. In the absence of international development, this may be a cost and time effective compromise between the WHO approach to instrument development and translation. The translation process usually reveals difficulties when adapting the format, instructions, concepts, idiomatic expressions, response scales or demographic items to different languages. The translatability assessment proposes to review these aspects and suggest re-formulations in the original considering the context and constraints of other languages/cultures.
RESULTS:
Several examples of the impact of the Translatability Assessment on the original wording will be given. For instance, although the term "work" in English Simultaneous global pharmaceutical development, registration and outcomes research (OR) strategies are now commonplace. However, incorporating Japan into global OR plans is a challenge. OBJECTIVE: This paper addresses the concerns of global OR researchers by presenting a systematic approach to incorporating Japan into global research protocols and strategies. METHODS: Informal interviews with managers involved in global R&D or OR planning and a literature review of pharmacoeconomic studies was conducted. Based on knowledge gained from several years of actual experience conducting outcomes research in Japan, these information sources were synthesized into a recommended approach for incorporating Japan into global OR plans. RESULTS: 39 published studies were found in the Japanese and English literature from 1980-2001, however , no mention of global research protocols was found. Based on interviews three activities were recom-
